These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 18949658

  • 1. Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation.
    Suzuki Y, Tanaka K, Neghishi D, Shimizu M, Murayama N, Hashimoto T, Yamazaki H.
    Xenobiotica; 2008 Dec; 38(12):1471-5. PubMed ID: 18949658
    [Abstract] [Full Text] [Related]

  • 2. Increased transendothelial permeability of anti-cancer agent carboplatin with the aid of hyperbaric oxygenation.
    Yamazaki H, Shimizu M, Murayama N, Tanaka K, Nion S, Cecchelli R.
    Xenobiotica; 2008 Oct; 38(10):1298-304. PubMed ID: 18798124
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
    Chen CL, Sun MH, Tan DC, Liang LZ.
    Ai Zheng; 2004 Nov; 23(11 Suppl):1405-8. PubMed ID: 15566645
    [Abstract] [Full Text] [Related]

  • 4. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
    Ohguri T, Imada H, Narisada H, Yahara K, Morioka T, Nakano K, Miyaguni Y, Korogi Y.
    Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C, Matsumoto K, Kuriyama M, Adachi H, Ono Y, Higashi H, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [Abstract] [Full Text] [Related]

  • 7. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
    Emerich DF, Snodgrass P, Dean R, Agostino M, Hasler B, Pink M, Xiong H, Kim BS, Bartus RT.
    Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infusion rates and drug distribution in brain tumor models in rats.
    Khan A, Jallo GI, Liu YJ, Carson BS, Guarnieri M.
    J Neurosurg; 2005 Jan; 102(1 Suppl):53-8. PubMed ID: 16206734
    [Abstract] [Full Text] [Related]

  • 10. Chemoembolization of lung metastases--pharmacokinetic behaviour of carboplatin in a rat model.
    Pohlen U, Rieger H, Meyer BT, Loddenkemper C, Buhr HJ, Heitland P, Koester HD, Schneider P.
    Anticancer Res; 2007 Jan; 27(2):809-15. PubMed ID: 17465206
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic investigation of increased efficacy against malignant gliomas of carboplatin combined with hyperbaric oxygenation.
    Suzuki Y, Tanaka K, Negishi D, Shimizu M, Yoshida Y, Hashimoto T, Yamazaki H.
    Neurol Med Chir (Tokyo); 2009 May; 49(5):193-7; discussion 197. PubMed ID: 19465788
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic comparison between systemic and local chemotherapy by carboplatin in dogs.
    Chen C, Wang W, Zhou H, Huang J, Liu P, Song T, Sun M.
    Reprod Sci; 2009 Nov; 16(11):1097-102. PubMed ID: 19657143
    [Abstract] [Full Text] [Related]

  • 15. [Intraperitoneal and intrathoracic administration of hydroxyapatite-carboplatin (HAp-CBDCA)].
    Mohri N, Mizuno I, Akamo Y, Takeyama H, Manabe T.
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1791-3. PubMed ID: 10560396
    [Abstract] [Full Text] [Related]

  • 16. Treatment of peritoneal carcinomatosis using carboplatin-loaded hydroxyapatite particles.
    Takeyama H, Mohri N, Mizuno I, Akamo Y, Sawai H, Manabe T, Yotsuyanagi T, Nakamura S.
    Anticancer Res; 2006 Oct; 26(6B):4603-6. PubMed ID: 17201184
    [Abstract] [Full Text] [Related]

  • 17. Dose-banding of carboplatin: rationale and proposed banding scheme.
    Kaestner S, Sewell G.
    J Oncol Pharm Pract; 2007 Jun; 13(2):109-17. PubMed ID: 17873111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues.
    Guarnieri M, Carson BS, Khan A, Penno M, Jallo GI.
    J Neurosci Methods; 2005 Jun 15; 144(2):147-52. PubMed ID: 15910972
    [Abstract] [Full Text] [Related]

  • 20. The effect of hyperbaric oxygen on regional brain and spinal cord levels of nitric oxide metabolites in rat.
    Ohgami Y, Chung E, Shirachi DY, Quock RM.
    Brain Res Bull; 2008 Mar 28; 75(5):668-73. PubMed ID: 18355644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.